相关实验视频

Updated: Jan 10, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

在初级保健中实施非侵入性肝病查工具

Klaudia Nowak¹, Adrian Nowak¹, Aleksandra Jabłońska¹

¹Collegium Medicum, Jan Kochanowski University, Kielce, Poland.

Korean journal of family medicine

|November 26, 2025

概括

非侵入性测试显示,在初级保健中早期检测代谢功能障碍相关的脂肪性肝病 (MASLD) 是有前途的. 克服资金和培训等障碍对于广泛采用和预防晚期肝病至关重要.

科学领域:

肝病学肝病学是一种肝病学.
公共卫生公共卫生
诊断医学诊断医学诊断医学

背景情况:

与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的全球健康问题,影响了超过三分之一的人口.
早期检测至关重要,以防止进展到严重的肝脏疾病,如纤维化,肝硬化和癌症.
肝脏活检,目前的黄金标准,是侵入性和不切实际的广泛查.

研究的目的:

探索关于非侵入性肝病查工具的当前观点.
评估这些工具在初级保健机构的实施情况.
确定用于常规使用非侵入性MASLD查的障碍物和促进者.

主要方法:

审查当前的非侵入性查工具,包括基于血清的指数和成像技术.
评估新的生物标志物 (例如,增强性肝纤维化试验,Pro-C3) 和人工智能辅助平台.
对实施挑战和初级保健中成功查模型的分析.

主要成果:

血清指数和成像显示了识别晚期纤维化的潜力.
新型生物标志物和人工智能平台提供了更好的准确性和风险分层.
障碍包括资金,指导方针,培训和访问;逐步选模型提高了效率.

结论:

非侵入性测试是可行的,并且成本效益高,用于初级保健中早期检测MASLD.
解决后勤,教育和系统障碍对于成功实施至关重要.
未来的努力应该集中在人工智能集成,便携式设备和个性化风险模型上.

关键词:

肝脏疾病肝脏疾病肝功能测试肝功能测试代谢疾病代谢疾病初级医疗保健是一项主要的医疗保健.

更多相关视频

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

Serum Laboratory Studies, Stool Test, Breath Test

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...